Etamsylate

酚磺乙胺

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameEtamsylate
Drug Alias NameetamsylatumetamsilatoDicyneneDicynoneMD-141 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHemorrhageThrombocytopeniaHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Zhejiang UniversityXuzhou Ryen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhageThrombocytopeniaHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeB02BX01
Related LinksWikipediaKEGG